W. P. Carey Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that W. P. Carey Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.72B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.58B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.74B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.48B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.33B | Feb 9, 2024 |
| FY2020 | Dec 31, 2020 | $307.37M | Feb 12, 2021 |
| FY2020 | Sep 30, 2020 | $302.42M | Feb 12, 2021 |
| FY2020 | Jun 30, 2020 | $290.53M | Feb 12, 2021 |
| FY2020 | Mar 31, 2020 | $309.00M | Feb 12, 2021 |
| FY2020 | Dec 31, 2019 | $311.23M | Feb 12, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $466.36M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $460.84M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $708.33M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $599.14M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $409.99M | Feb 9, 2024 |
| FY2020 | Dec 31, 2020 | $134.57M | Feb 12, 2021 |
| FY2020 | Sep 30, 2020 | $149.40M | Feb 12, 2021 |
| FY2020 | Jun 30, 2020 | $105.30M | Feb 12, 2021 |
| FY2020 | Mar 31, 2020 | $66.09M | Feb 12, 2021 |
| FY2020 | Dec 31, 2019 | $129.37M | Feb 12, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $209.88M | Feb 26, 2016 |
| FY2015 | Dec 31, 2014 | $223.94M | Feb 26, 2016 |
| FY2015 | Dec 31, 2013 | $85.89M | Feb 26, 2016 |
| FY2014 | Dec 31, 2012 | $94.34M | Mar 17, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.28B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.83B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.07B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.00B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $926.48M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $801.54M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $812.08M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $509.17M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $520.66M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $546.80M | Feb 25, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.99B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $17.54B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $17.98B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $18.10B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $15.48B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $14.71B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $14.06B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $14.18B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $8.23B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $8.45B | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.86B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $9.10B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $9.27B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $9.09B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $7.90B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $7.83B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $7.11B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $7.35B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $4.82B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $5.03B | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.12B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $8.43B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $8.70B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $8.99B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $7.58B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $6.88B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $6.94B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $6.82B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $3.19B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $3.30B | Feb 23, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $987.07M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $967.84M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $978.29M | Feb 11, 2026 |
| FY2025 | Dec 31, 2022 | $1.04B | Feb 11, 2026 |
| FY2024 | Dec 31, 2021 | $901.53M | Feb 12, 2025 |
| FY2023 | Dec 31, 2020 | $910.82M | Feb 9, 2024 |
| FY2022 | Dec 31, 2019 | $934.69M | Feb 10, 2023 |
| FY2021 | Dec 31, 2018 | $920.94M | Feb 11, 2022 |
| FY2020 | Dec 31, 2017 | $643.96M | Feb 12, 2021 |
| FY2019 | Dec 31, 2016 | $635.92M | Feb 21, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $155.33M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $640.37M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $633.86M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $168.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $165.43M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $248.66M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $196.03M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $217.64M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $162.31M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $155.48M | Feb 25, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.72B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $8.04B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $8.14B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $7.88B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $6.79B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $6.70B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $6.05B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $6.38B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $4.27B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $4.44B | Feb 23, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 1 | Feb 25, 2019 |
| FY2018 | Sep 30, 2018 | 0 | Feb 25, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Feb 25, 2019 |
| FY2018 | Mar 31, 2018 | 0 | Feb 25, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Feb 25, 2019 |
| FY2018 | Sep 30, 2017 | 0 | Feb 25, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Feb 25, 2019 |
| FY2018 | Mar 31, 2017 | 0 | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Feb 23, 2018 |
| FY2017 | Sep 30, 2016 | 1 | Feb 23, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 1 | Feb 25, 2019 |
| FY2018 | Sep 30, 2018 | 0 | Feb 25, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Feb 25, 2019 |
| FY2018 | Mar 31, 2018 | 0 | Feb 25, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Feb 25, 2019 |
| FY2018 | Sep 30, 2017 | 0 | Feb 25, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Feb 25, 2019 |
| FY2018 | Mar 31, 2017 | 0 | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Feb 23, 2018 |
| FY2017 | Sep 30, 2016 | 1 | Feb 23, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 219.15M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 218.85M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 218.67M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 210.62M | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | 190.01M | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | 175.40M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | 172.28M | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | 165.28M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | 106.92M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | 106.29M | Feb 23, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $790.03M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $765.15M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $916.53M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $835.26M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $764.28M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $726.96M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $704.40M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $440.43M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $431.18M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $416.66M | Feb 25, 2019 |